Welcome to LookChem.com Sign In|Join Free
  • or
5-Bromovaleryl chloride is a clear colorless to slightly yellow liquid that is utilized in various chemical processes and applications due to its unique properties.

4509-90-4

Post Buying Request

4509-90-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4509-90-4 Usage

Uses

Used in Chemical Synthesis:
5-Bromovaleryl chloride is used as a key intermediate in the synthesis of aromatic azides. These compounds are essential in the production of various pharmaceuticals and agrochemicals, as well as in the creation of dyes and pigments.
Used in Material Science:
In the field of material science, 5-Bromovaleryl chloride is used as a precursor for the development of organic gelators. These gelators have potential applications in the creation of soft materials, such as hydrogels and organogels, which can be utilized in drug delivery systems, sensors, and other advanced materials.

Check Digit Verification of cas no

The CAS Registry Mumber 4509-90-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,0 and 9 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4509-90:
(6*4)+(5*5)+(4*0)+(3*9)+(2*9)+(1*0)=94
94 % 10 = 4
So 4509-90-4 is a valid CAS Registry Number.
InChI:InChI=1S/C5H8BrClO/c6-4-2-1-3-5(7)8/h1-4H2

4509-90-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A18046)  5-Bromovaleryl chloride, 98%   

  • 4509-90-4

  • 5g

  • 514.0CNY

  • Detail
  • Alfa Aesar

  • (A18046)  5-Bromovaleryl chloride, 98%   

  • 4509-90-4

  • 25g

  • 1237.0CNY

  • Detail
  • Alfa Aesar

  • (A18046)  5-Bromovaleryl chloride, 98%   

  • 4509-90-4

  • 100g

  • 4330.0CNY

  • Detail
  • Aldrich

  • (331317)  5-Bromovalerylchloride  97%

  • 4509-90-4

  • 331317-5G

  • 613.08CNY

  • Detail
  • Aldrich

  • (331317)  5-Bromovalerylchloride  97%

  • 4509-90-4

  • 331317-25G

  • 2,248.74CNY

  • Detail

4509-90-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromovaleryl Chloride

1.2 Other means of identification

Product number -
Other names 5-Bromovaleroyl Chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4509-90-4 SDS

4509-90-4Synthetic route

5-bromopentanoic acid
2067-33-6

5-bromopentanoic acid

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Conditions
ConditionsYield
With thionyl chloride100%
With oxalyl dichloride In benzene at 20 - 50℃; Inert atmosphere;98%
With oxalyl dichloride In benzene at 50℃; for 3h;97%
5-Bromvaleriansaeuretrimethylsilylester
71250-83-4

5-Bromvaleriansaeuretrimethylsilylester

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Conditions
ConditionsYield
With thionyl chloride
δ-bromo-n-valeric acid

δ-bromo-n-valeric acid

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Conditions
ConditionsYield
With thionyl chloride
3,4,5,6-tetrahydro-2H-pyran-2-one
542-28-9

3,4,5,6-tetrahydro-2H-pyran-2-one

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: SOCl2
View Scheme
oxalyl dichloride
79-37-8

oxalyl dichloride

5-bromopentanoic acid
2067-33-6

5-bromopentanoic acid

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Conditions
ConditionsYield
In N-methyl-acetamide; dichloromethane
In N-methyl-acetamide; dichloromethane
5-bromopentanoic acid
2067-33-6

5-bromopentanoic acid

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Conditions
ConditionsYield
With oxalyl dichloride In dichloromethane at 20℃;
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

methoxybenzene
100-66-3

methoxybenzene

5-bromo-1-(4-methoxyphenyl)pentan-1-one
69287-12-3

5-bromo-1-(4-methoxyphenyl)pentan-1-one

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane at 0 - 20℃; for 2h;100%
With aluminium trichloride Friedel-Crafts acylation;85%
With aluminum (III) chloride In dichloromethane at 0 - 20℃; for 2h; Friedel-Crafts Acylation;
With metallic chloride at 50℃; Friedel-Crafts Acylation;
With aluminum (III) chloride In dichloromethane at 0 - 20℃; Inert atmosphere;
propylamine
107-10-8

propylamine

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

5-Bromo-pentanoic acid propylamide
442913-00-0

5-Bromo-pentanoic acid propylamide

Conditions
ConditionsYield
With pyridine In dichloromethane100%
In N,N-dimethyl-formamide
In N,N-dimethyl-formamide
3-(3-pyridyl)propan-1-ol
2859-67-8

3-(3-pyridyl)propan-1-ol

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

5-bromo-pentanoic acid 3-pyridin-3-yl-propyl ester

5-bromo-pentanoic acid 3-pyridin-3-yl-propyl ester

Conditions
ConditionsYield
With pyridine In dichloromethane100%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

benzyl alcohol
100-51-6

benzyl alcohol

Benzyl 5-bromovalerate
60343-28-4

Benzyl 5-bromovalerate

Conditions
ConditionsYield
With pyridine In dichloromethane100%
With triethylamine In dichloromethane at 0 - 20℃; for 16.5h;100%
With triethylamine In dichloromethane at 0 - 20℃;
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

(naphth-1-yl)methylamine
118-31-0

(naphth-1-yl)methylamine

5-bromo-pentanoic acid (naphthalen-1-ylmethyl)-amide

5-bromo-pentanoic acid (naphthalen-1-ylmethyl)-amide

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 1h;100%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

5-bromo-N-methoxy-N-methylpentanamide
130250-58-7

5-bromo-N-methoxy-N-methylpentanamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 25℃; for 12h;100%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

3-(3-bromophenyl)-1H-pyrazol-5-amine
149246-81-1

3-(3-bromophenyl)-1H-pyrazol-5-amine

5-bromo-pentanoic acid [5-(3-bromo-phenyl)-2H-pyrazol-3-yl]-amide
1040724-62-6

5-bromo-pentanoic acid [5-(3-bromo-phenyl)-2H-pyrazol-3-yl]-amide

Conditions
ConditionsYield
In ISOPROPYLAMIDE at 0℃; for 1h;100%
In ISOPROPYLAMIDE at 0℃; for 1h;
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

2-aminophenethyl alcohol
5339-85-5

2-aminophenethyl alcohol

5-bromo-N-[2-(2-hydroxyethyl)phenyl]pentanamide
1430091-95-4

5-bromo-N-[2-(2-hydroxyethyl)phenyl]pentanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at -5 - 0℃;100%
With triethylamine In dichloromethane at -5 - 0℃;100%
4-chloro-2-butyn-1-amine
87876-05-9

4-chloro-2-butyn-1-amine

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

5-bromo-N-(4-chlorobut-2-ynyl)pentanamide

5-bromo-N-(4-chlorobut-2-ynyl)pentanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at -5 - 20℃; for 2h;100%
4-amino-1-benzylpiperidine
50541-93-0

4-amino-1-benzylpiperidine

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

N-(1-benzylpiperidin-4-yl)-5-bromopentanamide

N-(1-benzylpiperidin-4-yl)-5-bromopentanamide

Conditions
ConditionsYield
With potassium carbonate In water; ethyl acetate for 1h;99%
With triethylamine In dichloromethane at 20℃;61%
With aq. KCO3 In ethyl acetate at 20℃; for 1h;
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

4-bromo-aniline
106-40-1

4-bromo-aniline

5-bromo-N-(4-bromophenyl)pentanamide
948883-07-6

5-bromo-N-(4-bromophenyl)pentanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0℃; for 3h;99%
With triethylamine In dichloromethane at 0℃; for 1h;86%
With triethylamine In DCE at 20℃;
dimethylenecyclourethane
497-25-6

dimethylenecyclourethane

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

3-(5-bromopentanoyl)oxazolidin-2-one
1330681-59-8

3-(5-bromopentanoyl)oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: dimethylenecyclourethane With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.25h; Inert atmosphere;
Stage #2: 5-bromovaleroyl chloride In tetrahydrofuran; hexane at -78 - 20℃; for 1.5h; Inert atmosphere;
99%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

C21H20F3N3O2

C21H20F3N3O2

C26H27BrF3N3O3

C26H27BrF3N3O3

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 3h; Cooling with ice;99%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

H-Phe-OEt
3081-24-1

H-Phe-OEt

(S)-2-(5-Bromo-pentanoylamino)-3-phenyl-propionic acid ethyl ester
170798-06-8

(S)-2-(5-Bromo-pentanoylamino)-3-phenyl-propionic acid ethyl ester

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 1h; Ambient temperature;98%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

4-methoxycarbonyl aniline
619-45-4

4-methoxycarbonyl aniline

4-(5-Bromo-pentanoylamino)-benzoic acid methyl ester
195191-89-0

4-(5-Bromo-pentanoylamino)-benzoic acid methyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 25℃; for 1.5h;98%
chloraminophenamide
121-30-2

chloraminophenamide

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

N-[2,4-bis(aminosulfonyl)-5-chlorophenyl]-5-bromo-pentanamide
907625-19-8

N-[2,4-bis(aminosulfonyl)-5-chlorophenyl]-5-bromo-pentanamide

Conditions
ConditionsYield
In 1,4-dioxane for 2h; Heating / reflux;98%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

C51H101NO4

C51H101NO4

C56H108BrNO5

C56H108BrNO5

Conditions
ConditionsYield
With dmap; triethylamine In benzene at 20℃;98%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

Diethyl iminodiacetate
6290-05-7

Diethyl iminodiacetate

C13H22BrNO5
1132801-02-5

C13H22BrNO5

Conditions
ConditionsYield
With triethylamine In acetonitrile at 0 - 20℃; for 2h;97.7%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

(-)-N-{2-[3-acetyl-5-(2-oxopiperidino)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl]ethyl}methanesulfonamide

(-)-N-{2-[3-acetyl-5-(2-oxopiperidino)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl]ethyl}methanesulfonamide

Conditions
ConditionsYield
With pyridine; sodium acetate97%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

methyl-4-cyanobenzylamine
34403-48-0

methyl-4-cyanobenzylamine

5-bromo-N-[(4-cyanophenyl)methyl]-N-methylpentanamide
633699-38-4

5-bromo-N-[(4-cyanophenyl)methyl]-N-methylpentanamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 5h;97%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

3-bromo-2-methylaniline
55289-36-6

3-bromo-2-methylaniline

1-(3-bromo-2-methylphenyl)piperidin-2-one
1231891-49-8

1-(3-bromo-2-methylphenyl)piperidin-2-one

Conditions
ConditionsYield
Stage #1: 5-bromovaleroyl chloride; 3-bromo-2-methylaniline With triethylamine In dichloromethane at 20℃; for 0.5h;
Stage #2: With sodium hydride In tetrahydrofuran at 20℃;
Stage #3: With hydrogenchloride; water In tetrahydrofuran
97%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

4-nitro-aniline
100-01-6

4-nitro-aniline

1-(4-nitrophenyl)piperidine-2-one
38560-30-4

1-(4-nitrophenyl)piperidine-2-one

Conditions
ConditionsYield
Stage #1: 5-bromovaleroyl chloride; 4-nitro-aniline With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃;
Stage #2: With potassium tert-butylate In tetrahydrofuran at 0 - 20℃;
96%
With pyridine; dmap In tetrahydrofuran at 0 - 100℃; for 1h;96.82%
Stage #1: 5-bromovaleroyl chloride; 4-nitro-aniline In tetrahydrofuran; water at 20℃; for 1h; Green chemistry;
Stage #2: In tetrahydrofuran; water at 20℃; for 4h; Green chemistry;
90%
Stage #1: 5-bromovaleroyl chloride; 4-nitro-aniline With triethylamine In tetrahydrofuran at 0 - 20℃;
Stage #2: With potassium tert-butylate In tetrahydrofuran at 0 - 20℃;
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

C11H12Cl2N2O

C11H12Cl2N2O

5-bromo-N-[4-(3,3-dichloro-2-oxopiperidin-1-yl)phenyl]valeroyl amide

5-bromo-N-[4-(3,3-dichloro-2-oxopiperidin-1-yl)phenyl]valeroyl amide

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 0.5h;96.04%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

cholesterol
57-88-5

cholesterol

cholest-5-en-3-β-yl 5-bromopentanoate
86689-84-1

cholest-5-en-3-β-yl 5-bromopentanoate

Conditions
ConditionsYield
With pyridine for 1h;96%
With pyridine In dichloromethane at 0 - 24℃; for 1h;96%
With pyridine In tetrahydrofuran at 0 - 20℃; for 12h;84%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

methyl 6-chloroanthranilate
41632-04-6

methyl 6-chloroanthranilate

methyl 2-(5-bromopentanoylamino)-6-chlorobenzoate
864387-30-4

methyl 2-(5-bromopentanoylamino)-6-chlorobenzoate

Conditions
ConditionsYield
With pyridine In tetrahydrofuran at 0 - 20℃; for 1h;96%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

tert-butyl N-(2-amino-6-methyl-phenyl)-N-(4-cyano-phenyl)-hydrazinocarboxylate
1075282-08-4

tert-butyl N-(2-amino-6-methyl-phenyl)-N-(4-cyano-phenyl)-hydrazinocarboxylate

tert-butyl N-[2-(5-bromo-pentanoylamino)-6-methylphenyl]-N-(4-cyano-phenyl)-hydrazinocarboxylate
1075282-10-8

tert-butyl N-[2-(5-bromo-pentanoylamino)-6-methylphenyl]-N-(4-cyano-phenyl)-hydrazinocarboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;96%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

benzyl N-[(1R,2R)-2-aminocyclohexyl]carbamate
142350-85-4

benzyl N-[(1R,2R)-2-aminocyclohexyl]carbamate

benzyl (1R,2R)-2-(5-bromopentanamido)cyclohexylcarbamate
1438415-81-6

benzyl (1R,2R)-2-(5-bromopentanamido)cyclohexylcarbamate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 5 - 20℃; for 2h;96%
5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

tert-butyl (3S,4S)-3-amino-4-hydroxypiperidine-1-carboxylate

tert-butyl (3S,4S)-3-amino-4-hydroxypiperidine-1-carboxylate

C15H27BrN2O4
1510832-71-9

C15H27BrN2O4

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 0℃; for 1h;96%
5-(2-aminophenyl)-10,15,20-triphenylporphyrinate
69082-94-6

5-(2-aminophenyl)-10,15,20-triphenylporphyrinate

5-bromovaleroyl chloride
4509-90-4

5-bromovaleroyl chloride

meso-triphenylporphyrin
80441-46-9

meso-triphenylporphyrin

Conditions
ConditionsYield
With ammonium hydroxide In tetrahydrofuran at 0℃; for 0.5h;95%
Stage #1: 5-(2-aminophenyl)-10,15,20-triphenylporphyrinate; 5-bromovaleroyl chloride In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: With ammonia In tetrahydrofuran; water
95%
With pyridine In dichloromethane for 10h; Ambient temperature;65%

4509-90-4Relevant academic research and scientific papers

Synthesis and biological activity of homologous piperidine-containing alkyl glycerolipids

Romanova,Serebrennikova,Shtil

, p. 641 - 644 (2009)

The paper provides the synthesis of new phosphorless glycerolipids with an ether bond that contain heterocyclic bases in the polar domain. The physico-chemical characteristics and biological activity of the prepared compounds were studied.

Iron(II) complex of octopus-porphyrin with a covalently linked proximal imidazole; self-assembly and O2-coordination in aqueous media

Komatsu,Hayakawa,Yanagimoto,Kobayakawa,Nakagawa,Tsuchida

, p. 1703 - 1707 (2001)

The iron complex of tetrakis[2,6-di(alkanoyloxy)phenyl]porphyrin derivative with seven phosphocholine head groups and an N-alkylimidazole side-chain as the proximal base (octopus-porphyrin) has been synthesized. The ferrous complex (7b) was easily dispersed in water to provide a stable colloid. Transmission electron microscopy and scanning force microscopy of the evaporated solution showed spherical micelles with a diameter of 8 nm, which probably consists of a dimer of 7b. These micellar aggregates could reversibly coordinate O2 at 25 °C and the O2-binding parameters are also given.

Formal synthesis of (+)-tashiromine and study toward the total synthesis of (+)-stemoamide

Chen, Yue-Jie,Bao, Rui-Yang,Zhang, Xiao-Dong,Tang, Ye-Feng

, p. 953 - 956 (2013)

An efficient formal synthesis of (+)-tashiromine was achieved by employing an intermolecular asymmetric Mannich-type reaction as the key step. Concurrently, a novel approach toward the total synthesis of (+)-stemoamide through dyotropic rearrangement of 3,4-cis-β-lactone was also explored.

β-Cyclodextrin Host-Guest Complexes Probed under Thermodynamic Equilibrium: Thermodynamics and AFM Force Spectroscopy

Auletta, Tommaso,De Jong, Menno R.,Mulder, Alart,Van Veggel, Frank C. J. M.,Huskens, Jurriaan,Reinhoudt, David N.,Zou, Shan,Zapotoczny, Szczepan,Schoenherr, Holger,Vancso, G. Julius,Kuipers, Laurens

, p. 1577 - 1584 (2004)

The rupture forces of individual host-guest complexes between β-cyclodextrin (β-CD) heptathioether monolayers on Au(111) and several surface-confined guests were measured in aqueous medium by single molecule force spectroscopy using an atomic force microscope, Anilyl, toluidyl, tert-butylphenyl, and adamantylthiolss (0.2-1%) were immobilized in mixed monolayers with 2-mercaptoethanol on gold-coated AFM tips, For all guests and for all surface coverages, the force-displacement curves measured between the functionalized tips and monolayers of β-CD exhibited single, as well as multiple, pull-off events, The histograms of the pull-off forces showed several maxima at equidistant forces, with force quanta characteristic for each guest of 39 ± 15, 45 ± 15, 89 ± 15, and 102 ± 15 pN, respectively. These force quanta were independent of the loading rate, indicating that, because of the fast complexation/decomplexation kinetics, the rupture forces were probed under thermodynamic equilibrium. The force values followed the same trend as the free binding energy ΔG° measured for model guest compounds in solution or on β-CD monolayers, as determined by microcalorimetry and surface plasmon resonance measurements, respectively, A descriptive model was developed to correlate quantitatively the pull-off force values with the ΔG° of the complexes, based on the evaluation of the energy potential landscape of tip-surface interaction.

Brassinosteroid-BODIPY conjugates: Design, synthesis, and properties

Malachowska-Ugarte, Magdalena,Sperduto, Claudio,Ermolovich, Yuri V.,Sauchuk, Alina L.,Jurá?ek, Michal,Litvinovskaya, Raisa P.,Straltsova, Darya,Smolich, Igor,Zhabinskii, Vladimir N.,Dra?ar, Pavel,Demidchik, Vadim,Khripach, Vladimir A.

, p. 53 - 59 (2015)

Three BS-BODIPY (brassinosteroids-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) conjugates were synthesized and their fluorescent and immunological properties were investigated. Two of the conjugates, having present all the functional groups characteristic of BS, were shown to be potentially useful as biological probes to study involvement of BS into physiological processes in living cells.

Nucleic acid-induced aggregation and pyrene excimer formation

Zhang, Ruixing,Tang, Dan,Lu, Ping,Yang, Xiangyu,Liao, Dongli,Zhang, Yujing,Zhang, Mingjun,Yu, Cong,Yam, Vivian W. W.

, p. 4302 - 4305 (2009)

Nucleic acid was found to induce the aggregation of the positively charged pyrene probe (compound 1); as a result, strong pyrene excimer emission was observed. The Intensity of the excimer emission was dependent on the concentration of the pyrene probe and the oligonucleotide length, sequence, and concentration. These results suggest a new strategy for label-free nucleic acid-based biosensing applications.

Synthesis of novel C-2- or C-15-labeled BODIPY—estrone conjugates

Bacsa, Ildikó,Konc, Csilla,Orosz, Anna Boglárka,Kecskeméti, Gábor,Rigó, Réka,zvegy-Laczka, Csilla,Mernyák, Erzsébet

, (2018)

Novel BODIPY–estrone conjugates were synthesized via Cu(I)-catalyzed azide–alkyne cycloaddition (CuAAC). Estrone-alkynes or an estrone-azide as starting compounds were synthesized via Michael addition or Sonogashira reaction as key steps. Fluorescent dyes based on BODIPY-core were provided by azide or alkyne functional groups. Fluorescent labeling of estrone was efficiently achieved at the C-2 or C-15 position. The newly-elaborated coupling procedures might have a broad applicability in the synthesis of fluorescent-labeled estrone conjugates suitable for biological assays.

Oseltamivir PROTAC compound as well as preparation method and application thereof in anti-influenza virus medicines

-

Paragraph 0048-0051, (2021/04/03)

The invention discloses an oseltamivir PROTAC compound as well as a preparation method and application thereof in anti-influenza virus medicines, and belongs to the technical field of medicines. The oseltamivir PROTAC compound is shown as a general formula (I) or (II), and in the general formula, E3 ligase is a VHL or CRBN ligand, and Linker is a linking group. The compound provided by the invention can effectively degrade influenza virus neuraminidase so as to exert the activity of inhibiting influenza virus replication, not only has inhibitory activity on wild influenza viruses, but also hasa very good inhibitory effect on oseltamivir drug-resistant strains, and has low toxicity to cells. The compound or the pharmacologically or physiologically acceptable salt thereof can be used for preparing anti-influenza virus medicines.

PDE4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

-

Paragraph 0331, (2021/06/22)

Provided herein are phosphodiesterase 4 (PDE4) inhibitors, e.g., a compound of Formula (I) or (II), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disease, disorder, or condition associated with PDE4 malfunction.

Gemfibrozil derivatives as activators of soluble guanylyl cyclase – A structure-activity study

Baker, Hannah,Ferreira, Liam D.,Gayler, Kevin M.,Kane, Robert R.,Karunananthan, Johann W.,Kostyo, Jessica H.,Martin, Emil,Mattke, Jordan,Nguyen, Harold,Plunk, Michael A.,Quintana, Jeremy M.,Sharina, Iraida,Shuda, Mina,Stinchcomb, Alexandra L.

, (2021/08/09)

Previous studies demonstrated that anti-hyperlipidemic drug gemfibrozil acts as NO- and heme-independent activator of NO receptor soluble guanylyl cyclase. A series of new gemfibrozil derivatives were synthesized and evaluated for sGC activation. The structure-activity relationship study identified the positions in gemfibrozil's scaffold that are detrimental for sGC activation and those that are amendable for optimizing modifications. Compared with gemfibrozil, compounds 7c and 15b were more potent activators of cGMP-forming activity of purified sGC and exhibited enhanced relaxation of preconstricted mouse thoracic aorta rings. These studies established the overall framework needed for futher improvement of sGC activators based on gemfibrozil scaffold.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4509-90-4